Linlin Wang, Qi Dang, Yuan Yuan, Huang Yunjian, Jin Zhou, Shoumei Yang, Meili Sun, Shegan Gao, Ruinuo Jia, Leilei Yuan, Lin Zhao, Mudan Yang, Yanqiao Zhang, Jiang Zhao, Xiaoli Hou, Haoyu Yu, Jing Li, Qingyu Wang, Jun Zhu, Jinming Yu. "A multicenter, randomized phase 2 study evaluating the efficacy and safety of HLX43 (an anti-PD-L1 ADC) in recurrent/metastatic esophageal squamous cell carcinoma.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.2_suppl.364